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Abstract 
Note that the “Current Medical Research” feature focuses on issues relevant to natural family planning 
and the beginning of life. This piece is complemented by medical reviews published in The National 
Catholic Bioethics Quarterly, which focus more on other areas of general medical interest including 
end-of-life issues.—Ed. 
Retrospective Cohort Efficacy Study of Natural Procreative Interventions to 
Treat Infertility 
In the recent papal document Dignitas personae, Pope Benedict XVI called on Catholic physicians and 
scientists to develop ethical treatments for infertility that do not violate human dignity, the sanctity of 
life, and the marital bond. Thomas Hilgers, M.D., (an obstetrician-gynecologist) has developed, through 
many years of practice and study, what he calls natural procreative technology or NaProTech. 
NaProTech is a system of medical and surgical interventions that cooperates with the woman's natural 
menstrual cycle to treat infertility and other women's health problems (T. Hilgers, The Medical and 
Surgical Practice of NaProTECHNOLOGY [Omaha, NE: Pope Paul VI Institute, 2004]). A base practice of 
NaProTech is the reliance on menstrual cycle monitoring (through the use of natural family planning 
and in particular the Creighton Model System) as a means for assessment, treatment, and evaluation 
of outcomes. Hilgers also offers an intensive educational program for physicians, a program that trains 
them in the use of natural procreative technologies and the interpretation of the Creighton Model 
(CrM) system of natural family planning (NFP). Several primary care family medicine physicians recently 
reported on the efficacy of NaProTech methods in the treatment of infertility (J.B. Stanford, T.A. 
Parnell, and P.C. Boyle, “Outcomes from Treatment of Infertility with Natural Procreative Technology in 
an Irish General Practice,” Journal of the American Board of Family Medicine 21 [2008]: 375–384). One 
of the reasons for this article was to demonstrate that NaProTech methods could be used effectively 
and safely in a primary care practice—and that it is not necessary to refer women immediately to high-
tech and expensive infertility specialists who often utilize unethical means to obtain good outcomes. 
This retrospective cohort study involved 1,234 infertility patients from one family medical practice in 
Ireland during the years 1999–2006. Treatment involved having the woman patient track her fertility 
with the CrM system (which focuses primarily on the estrogenic changes in cervical mucus), assessing 
the timing of intercourse, evaluating the quality of cervical mucus production, measuring luteal phase 
lengths, and determining levels of progesterone and estrogen on certain days of the menstrual cycle. 
When menstrual cycle deficits were detected, treatment included the use of clomiphene (to stimulate 
ovulation), medications to stimulate cervical mucus production, and progesterone supplementation. 
The study involved the analysis of live births as an outcome over 24 months of care. 
The mean age of the couples in the study was 35.6 years, and the mean number of years of trying to 
conceive was 5.6. The gross live birth rate at 12 months of treatment was 27.6 percent and at 24 
months 33.9 percent. When the couples who withdrew prematurely were taken out of the analysis, the 
rates were 45 percent at 12 months and 56 percent at 24 months of treatment. The authors made 
comparisons with published IVF pregnancy rates and concluded that the results compare well with IVF 
treatments even though this study included a relatively older population of women. The authors 
emphasized that the comparison is very tentative due to the limitations of a non-comparison 
retrospective design. 
Comments: The development and implementation of NaProTechnology, an ethical system of treating 
infertility, is commendable. So too, is the desire to gather evidence for its efficacy as presented in this 
article. However, although this study provides some evidence for its efficacy, the level of evidence is 
somewhat low. The authors point this out clearly in the article and advocate the use of prospective 
cohort studies. It would be interesting to compare the use of natural procreative technologies with 
other ethical treatments, such as expectant waiting, lifestyle changes, or focused intercourse during 
the fertile phase. 
A medical critique could include the question as to whether the use of clomiphene, progesterone 
supplementation, mucus enhancers, the integration of menstrual cycle charting, and focused 
intercourse is new. Furthermore, there is the question of why other standard medical treatments were 
not mentioned, such as the use of metformin for polycystic ovaries. 
Clomifene Citrate and Intrauterine Insemination Found to be no More 
Effective than Expectant Waiting 
Approximately one quarter of all infertile couples have unexplained infertility. These couples are good 
candidates for low-cost methods of treatment, including the use of clomifene citrate (also known as 
clomiphene citrate), intrauterine insemination, and expectant waiting. Although single cohort studies 
have shown improvement with these methods, few studies have compared the relative efficacy of 
these methods in helping couples to achieve pregnancy. Furthermore, many of these studies have few 
participants, are not adequately designed, or do not have enough statistical power to show 
differences. Therefore, British scientists designed a study to compare the effectiveness of clomifene 
citrate and intrauterine insemination with expectant waiting (S. Bhattacharya et al., “Clomifene Citrate 
or Unstimulated Intrauterine Insemination Compared with Expectant Management for Unexplained 
Infertility: Pragmatic Randomised Controlled Trial,” British Medical Journal 337 [2008]: 716–723). 
The scientists used what they called a pragmatic randomized control trial design, in which they 
randomized 580 couples (who had at least two years of unexplained infertility and who exhibited 
bilateral tubal patency) from three hospitals in Scotland into one of three treatment arms, i.e., the 
administration of an oral dose of 50 mg of clomifene citrate (plus recommended intercourse on days 
12–18 of the menstrual cycle), intrauterine insemination within thirty hours of a self-identified 
luteinizing hormone surge, and expectant waiting. The couples were followed for 6 months to 
determine and confirm clinical pregnancies through ultrasound. The primary outcome was live birth 
rates. Secondary outcomes were clinical pregnancy rates, multiple birth pregnancy rate, adverse 
events, and anxiety and depression. 
The scientists found that the live birth rates for the clomefine group (N=194) was 26/192 (14 percent), 
for the intrauterine insemination group (N=193) it was 43/191 (23 percent), and for the expectant 
management group (N=93) 32/193 (17 percent). There were no statistical differences among the 
pregnancy rates of these three treatment groups. Furthermore, there were no differences in anxiety 
levels, depression levels, rate of multiple pregnancies, clinical pregnancy rates, and ectopic and 
miscarriage rates. However, the women in the active treatment group found the treatments to be 
more satisfying than expectant waiting. The authors concluded that the use of clomifene citrate or 
intrauterine insemination were unlikely to offer superior live birth rates compared to expectant 
management among couples with unexplained infertility. 
Comments: Although the women in the clomifene group experienced more abdominal pain, bloating, 
hot flushes, and headaches compared to women in the other treatment groups, they still felt that this 
treatment was more acceptable than the expectant waiting group. Obviously women in these groups 
had high hopes that some type of intervention would be a help and that doing nothing might be a 
waste of time. It would be interesting to conduct a double blind study in which the investigators and 
the participants did not know whether they were in a clomifene treatment group or a placebo group. 
Another study might have the expectant waiting group learn natural family planning, engage in focused 
intercourse during the fertile phase, and adopt lifestyle changes. These would allow this group to feel 
they were active in some type of treatment. The fact that the clomifene group had intercourse during 
days 12–18 might have enhanced their chances of pregnancy. 
Timed Intercourse Considered Possible Deleterious Intervention for Sub-
Fertile Couples Attempting Pregnancy 
H.K. Snick a physician scientist from the Netherlands has contended in past articles that there is no 
good evidence that purposeful timing of intercourse (even with the use of self-observed fertility 
indicators) helps to increase the time to pregnancy (H.K.A. Snick, “Should Spontaneous or Timed 
Intercourse Guide Couples Trying to Conceive?” Human Reproduction 20 [2005]: 2976–2969). He now 
maintains that timed intercourse might even impair fertility. In a recent study, he and other scientists 
sought to determine if timed intercourse was more effective than expectant management when timed 
intercourse was used as a control group in intrauterine insemination efficacy studies (H.K. Snick, J.A. 
Collins, and J. L. H. Evers, “What Is the Most Valid Comparison Treatment in Trials of Intrauterine 
Insemination, Timed or Uninfluenced Intercourse? A Systematic Review and Meta-Analysis of Indirect 
Evidence,” Human Reproduction 23 [2008]: 239–2245). 
The researchers were able to identify 11 studies from an extensive review of the existing literature that 
represented 13 trials of intrauterine insemination in comparison to either timed intercourse or 
expectant management. This review provided a comparison of intrauterine insemination with timed 
intercourse among 1,329 sub-fertile couples. They found the differences in pregnancy rates with 
intrauterine insemination in comparison with timed intercourse was 6.1 percent and with expectant 
management 3.9 percent. The adjusted difference in pregnancy rates between timed intercourse and 
expectant management was 2.8 percent. This difference in rates was not statistically significant. Even 
so, the researchers concluded that the use of timed intercourse as a control when comparing 
intrauterine insemination was not significantly different than expectant management, and they felt 
there was sufficient evidence to consider the possibility that pregnancy was less likely with timed 
intercourse. 
Comments: The authors of this article speculated as to why timed intercourse might be detrimental to 
fertility. First of all, they suggested that couples who follow their natural sexual instincts will most likely 
have intercourse during the most fertile days of the menstrual cycle. Secondly, they felt that by timing 
intercourse, especially by use of urinary LH markers, they might miss the most fertile days of the 
menstrual cycle (which are the 2 days before ovulation), and the cervical mucus (that nourishes the 
sperm) might be diminished. A third reason is that the couples might be stressed with having to have 
intercourse on a schedule that follows fertility markers. The evidence for timed intercourse impairing 
rather than aiding fertility is rather thin. Randomized comparison studies of timed intercourse with 
expectant management would help to further understanding of the mechanisms of intercourse 
patterns and fertility. 
Microscopic Structure of Cervical Mucus Appears to be Different in Women 
with Polycystic Ovarian Syndrome 
Polycystic ovarian syndrome is one of the most common endocrine-metabolic disorders for women of 
reproductive age, with an incidence of approximately 5–10 percent (P. Vigil et al., “Evidence of 
Subpopulations with Different Levels of Insulin Resistance in Women with Polycystic Ovary Syndrome,” 
Human Reproduction 22 [2007]: 2974–2980). Cervical mucus is reflective of the endocrine hormonal 
patterns of the menstrual cycle and is an essential component of fertility for couples wishing to achieve 
pregnancy through normal intercourse. P. Vigil listed a number of important functions of “healthy” 
cervical mucus including: 1) allowing for sperm transport, 2) filtering out abnormal sperm, 3) 
preventing a premature acrosome reaction, 4) protecting the female genital track, and 5) acting as an 
antimicrobrial barrier (P. Vigil et al., “Scanning Electron and Light Microscopy Study of the Cervical 
Mucus in Women with Polycystic Ovary Syndrome,” Journal of Electron Microscopy 58 [2009]: 21–27). 
The classification of the microscopic structures of cervical mucus has been described and developed 
principally by Odeblad and others, and includes the classic ferning structure of estrogenic type mucus 
and the dense structure of progestogenic mucus. Vigil and others carried out a descriptive comparative 
study to determine if there are microscopic structural differences in cervical mucus among women 
with normal menstrual cycles in comparison with women who have irregular cycle patterns due to 
polycystic ovarian syndrome (PCOS). 
Ten women were recruited as participants from a fertility clinic, of which 4 were controls with normal 
ovulatory menstrual cycles, 4 were women with PCOS and an-ovulatory menstrual cycles, and 2 
women with PCOS who demonstrated normal ovulatory menstrual cycles. Cervical mucus secretions 
were obtained from the women by aspiration from the cervical canal with a cannula. Urinary assays of 
metabolites of estrogen and progesterone were obtained on the day of the mucus aspiration and every 
5 days until the end of the menstrual cycle. Cervical mucus was observed both with the use of a 
scanning electron microscope and, at low power, with a light microscope. The researchers found that 
the cervical mucus structure and hormonal levels of the regularly ovulating control were similar. 
However, the cervical mucus structure of the PCOS non-ovulating women did not show the 
characteristic ferning patterns that one would expect with ovulatory estrogenic type mucus. 
Furthermore, the mucus had dense looking mesh structures that appeared impenetrable, and the 
urinary estrogen hormone levels were lower than those found with the ovulating women. The author 
suggested further studies to compare the difference in the glycoprotein structure of the cervical mucus 
from normal cycling women and from women who have PCOS. 
Comments: Limitations of this study included the low number of participants and the sporadic nature 
of cervical mucus and hormonal obtainment—especially having only 2 anovulatory women with PCOS. 
Women with PCOS often have multiple LH surges and multiple peaks (i.e., fertile type mucus patterns) 
throughout the menstrual cycle due to the multiple follicles at various levels of maturation. 
Natural Family Planning Content Included in 62 Percent of U.S. and Canadian 
Medical Schools 
In 1993 a group called Medical Students for Choice (MSFC) was formed due to the perceived lack of 
training content on contraception and abortion in medical schools throughout the United States and 
Canada (J. Steinauer et al., “First Impressions: What Are Pre-Clinical Medical Students in the U.S. and 
Canada Learning about Sexual and Reproductive Health?” Contraception 80 [2009]: 74–80). The group 
now has over 10,000 members and 134 chapters in medical schools in the U.S. and Canada. Two 
members of MSFC (medical school faculty sympathetic to the group) and a member of a reproductive 
health advocacy group recently conducted a survey of medical students to determine the inclusion of 
contraception and elective abortion content in U.S. and Canadian medical schools. A secondary 
purpose was to collect data to help reform medical school curricula in regards to reproductive health 
issues (i.e., abortion, contraception, homosexual health care). 
A survey was developed that included questions about many aspects of reproductive health, including 
pregnancy, infertility, contraceptive techniques, abortion techniques, reproductive ethics, and other 
women's health topics (e.g., sexual violence and homosexual safe-sex issues)—topics that followed 
Association of Professors of Gynecology and Obstetrics guidelines. The questionnaires were sent to 122 
MSFC coordinators of which 77 were returned (a 63 percent return rate) and included 68 U.S. schools 
and 9 Canadian. This return represented 68 of the 149 U.S. schools (46 percent) and 9 of the 17 
Canadian schools (53 percent). Most schools (97–100 percent) reported content in pregnancy 
physiology and sexually transmitted diseases. Seventy-three schools (95 percent) reported content on 
hormonal contraception (mostly in pharmacology classes), and 61 percent had content on medical 
abortion. Surgical first-trimester abortion and late-term abortion techniques were covered in 43 
percent and 28 percent of the medical schools respectively. Of interest is that 62 percent of medical 
schools had content on “rhythm/natural family planning.” However, fewer schools in the south (20 
percent) listed content in this area. The authors pointed out that the content on abortion and 
contraception varied widely among the medical schools contacted. They advocated that medical 
schools need to integrate content on comprehensive family planning into their standard curricula. 
Comments: The content on rhythm and natural family planning was probably very limited. It is sad that 
three of the five Catholic-sponsored medical schools have MSFC chapters—that advocate for abortion, 
contraception, and assisted suicide. The results of this study had many limitations, e.g., there was no 
control on how content was determined by the MSFC coordinators. 
Early Ovulation Considered Cause of Unintended Pregnancy among Women 
Using Hormonal Contraception and Rhythm 
Researchers hypothesized that there is a subset of women who ovulate early and for whom the usual 
pattern of hormonal contraception and calendar rhythm may not work as well, i.e., they will 
experience a high unintended pregnancy rate (E.R. Wiebe and J. Trussell, “Contraceptive Failure 
Related to Estimated Cycle Day of Conception Related to the Start of the Last Bleeding Episode,” 
Contraception 79 [2009]: 178–181). The researchers speculated that women who use the 21 days on 
and 7 days off type of hormonal contraception might be more susceptible for an unintended 
pregnancy. They were able to test this hypothesis because some abortion clinics (including at the site 
of one of the researchers) routinely conduct endovaginal ultrasound prior to an abortion in order to 
estimate the day of conception. The objective of this study was to determine the menstrual cycle day 
of conception by using the history of the last menstrual period and endovaginal ultrasound dating of 
the pregnancy. 
This was a retrospective chart audit study, in which all of the patients who obtained an abortion at two 
clinics between January and May of 2007 were included in the study. Data were taken from 913 charts, 
and the date of conception was estimated as the date of the ultrasound minus the estimated 
gestational age determined by ultrasound. The cycle day of conception was the estimated day of 
conception minus the woman's reported date of the last bleeding episode. 
Results showed that there were 99 women who were on hormonal contraception and had an 
unintended pregnancy, and of these 26 (26.3 percent) conceived between cycle day 1–9, and 73 (73.7 
percent) conceived between cycle day 10–40. This was in comparison to a total of 679 women who 
were using other forms of contraception, of which 100 (14.7 percent) conceived between cycle days 1–
9, and 579 (83.3 percent) conceived between cycle days 10–40. These results were considered 
statistically different by Fisher's exact test (p < 0.005). The researchers concluded that the data suggest 
that there is a sizable subset of women who ovulate earlier after onset of withdrawal bleeding when 
using the 21/7 hormonal contraceptives. 
Comments: Of interest is that women who had the most unintended pregnancies were those who used 
the condom (306 = 33.5 percent) followed by “other including none” (244 = 31.3 percent), oral 
hormonal contraception (90 = 9.9 percent), withdrawal (71 = 7.8 percent), and then rhythm (53 = 5.8 
percent). The women who listed “rhythm” most likely used a self-devised method, i.e., counting from 
the day of menses to when they thought the fertile time started (these women would be susceptible to 
an unintended pregnancy due to an early ovulation). However, these women most likely were not 
using a modern method of NFP nor were taught a true method of calendar rhythm. 
Evidence Shows Hormonal Oral Contraception Continues to be a Risk for 
Inflammatory Bowel Disease 
Environmental factors such as smoking and hormonal contraception have been implicated as risk 
factors for developing inflammatory bowel disease, i.e., Crohn's disease and ulcerative colitis. The 
theory is that hormonal contraception contributes to multi-focal small vascular infarctions in the bowel 
system. However, this association was originally established when the formulations of the early 
hormonal contraceptives had higher levels of estrogen and progestins. It is known that the risk for 
stroke has decreased due to lower levels of these dual hormones (in particular estrogen). What is not 
well known is the effect of lower hormonal dosages with the current formulations of oral hormonal 
contraceptives on the association with the development of inflammatory bowel disease. 
Researchers from England conducted a meta-analysis of case controlled studies that investigated the 
risk of Crohn's disease and ulcerative colitis with exposure to hormonal contraception controlling for 
smoking (J.A. Cornish et al., “The Risk of Oral Contraceptives in the Etiology of Inflammatory Bowel 
Disease: A Meta-Analysis,” American Journal of Gastroenterology 103 [2008]: 2394–2400). They 
utilized only studies that had a high quality scientific rating and were published since 1980. They were 
able to obtain 14 high quality studies that represented 36,797 women who were exposed to hormonal 
contraception and 39,018 who were not exposed to oral contraceptives. They found a 51 percent 
increase in relative risk for Crohn's disease and a 46 percent increased risk when adjusted for smoking. 
The increase in relative risk for ulcerative colitis for women taking oral contraceptives was 53 percent 
and 28 percent when adjusted for smoking. They also found an increased risk with length of use of oral 
contraceptives, i.e., an increase in relative risk of 41 percent at 6 months of use, 83 percent at 12 
months, and 248 percent at 3 years. The authors of the study concluded that the reduction of estrogen 
and progesterone content in the newer formulation of oral hormonal contraception has not reduced 
the relative risk of developing inflammatory bowel disease. However, they did caution that studies 
with negative results tend not to get published. 
Comments: Although the authors played down the risk for inflammatory bowel disease and stated that 
overall oral contraceptives are safe and healthy, it would be prudent for women with a family history 
of inflammatory bowel disease and taking oral contraceptives to be advised of the risk. 
Efficacy of Electronic Hormonal Monitoring plus Cervical Mucus Monitoring as 
a Method to Avoid Pregnancy 
Researchers and clinicians at Marquette University developed a method of natural family planning that 
utilizes self-monitoring of cervical mucus along with an electronic hormonal fertility monitor (EHFM) as 
a double check for the beginning and end of the fertile phase of the menstrual cycle. The EHFM is a 
handheld device that reads a threshold level of urinary metabolites of estrogen (estrone 3 glucuronide) 
and luteinizing hormone (LH) (on test strips) and provides the user with a low, high, and peak reading 
of fertility. The monitor is sold in the United States as a method to help couples achieve pregnancy but 
can be used as an aid to track fertility. 
A prospective efficacy study of this method was reported in an earlier issue of Natural Family Planning 
Current Medical Research and in the Journal of Obstetrics, Gynecological, and Neonatal Nursing.1 Since 
then two new efficacy studies of this method has been published, one study was a retrospective 
analysis of the method developed at Marquette,2 and the second was a retrospective cohort 
comparison of the Marquette method with a cervical mucus only method of NFP.3 
The retrospective study involved 204 couples (women with a mean age of 28.6 and their male partners 
with a mean age of 30.3) who were taught NFP (by health professionals, physicians, and professional 
nurses) at four sites in the United States (Saint Augustine, Florida; Atlanta; Saint Louis; and 
Milwaukee). Health professionals helped the couples decide which combination of fertility indicators, 
i.e., basal body temp (BBT), cervical mucus monitoring, CVM (cervical mucus monitoring), or EHFM fit 
best with their lifestyle and reproductive needs. There were a total of 12 unintended pregnancies, only 
one with correct use. The 12-month correct use pregnancy rate was 0.6 (i.e., 99.4 percent survival) and 
the typical use (total pregnancy rate) was 10.6 (i.e., 89.4 percent survival) per 100 users. See table 1 for 
a breakdown of the combination of fertility indicators utilized in the study. The researchers concluded 
that, when used correctly, the Marquette system of NFP is a very effective means of avoiding 
pregnancy. 
 
 
The second study was as retrospective cohort comparison of couples who were taught the Marquette 
method of NFP (but only those who used the EHFM along with CVM) in comparison to a CVM-only 
method.4 The participants for this study came from the same four clinic sites as the previous study and 
involved 313 couples who were taught how to avoid pregnancy with the EHFM plus CVM and another 
315 who used CVM only. Both methods involved standardized group teaching and individual follow-up. 
All unintended pregnancies were reviewed by health professionals, pregnancy rates (over 12 months of 
use) were determined by survival analysis, and comparisons of unintended pregnancy rates were made 
by use of the Fisher Exact test. The researchers found a total of 28 unintended pregnancies with the 
EFHM-plus-CVM group and 41 with the CVM-only group. The 12-month correct use pregnancy rate of 
the EHFM group was 2.0 percent, and the total pregnancy rate was 12.0 percent, in comparison with a 
3.0 percent correct use and 23.0 percent total pregnancy rate with the CVM-only group. There was a 
significant difference in the total pregnancies between the two groups applying the Fisher Exact test (p 
< 0.05). The researchers concluded that the EHFM-aided CVM method was more effective than the 
CVM-only method. 
Comments: Although both studies involved retrospective chart audits of the NFP methods utilized, all 
of the couples were taught the methods prospectively with standardized formats and follow-up 
sessions. Even so, both studies have limitations in that they were not randomized clinical trials. The 
differences in results of the EHFM plus CVM with CVM only could be due to factors other than use of 
the methods to avoid pregnancy—including investigator bias. However, the results do confirm earlier 
studies that compared CVM only with CVM plus BBT, and with later highly effective cohort studies of 
CVM plus BBT and calendar formulas as double checks for the beginning and end of the fertile phase of 
the menstrual cycle.5 
Under the Microscope 
Optimizing Natural Fertility: Frequency of Intercourse, Focused Intercourse, and Lifestyle 
Factors 
Couples in the United States and other Western nations are delaying marriage and postponing children 
for the purpose of developing careers and stabilizing relationships.1 Some risks of delaying childbirth to 
an older age is diminished fertility and the potential expense of infertility diagnosis and treatment.2 
Demographic studies have shown that there is a consistent decline in female fecundity with advancing 
age after 30–35 years.3 Studies based on the Natural Survey of Family Growth have shown that the 
prevalence of infertility after 12 months of attempting to achieve a pregnancy is only 6.7 percent 
among those 20–24 years of age, but increases to 16.1 percent among women 30–34 years and 22.9 
percent among women 35–39 years.4 
In the reproductive literature women are considered “older” at 30 years and beyond. There is evidence 
that male fertility also declines (although much slower than women) after the age of 40. Recent studies 
have suggested that older women (i.e., 35 years or older), especially with an older spouse, should be 
referred for infertility workup after only 6 months of trying.5 However, before engaging in expensive 
diagnosis and treatment for infertility, there are less expensive self-directed methods that have been 
shown to increase fertility and should be tried.6 Furthermore, couples with sub-fertility, with unknown 
reasons for infertility, or with mild male factor might benefit from these methods as well.7 
The following report reviews some of the recent literature on self-help measures to optimize fertility 
and aid in the time to pregnancy. These measures include the timing and frequency of intercourse, 
tracking natural fertility indicators to determine the best time for intercourse, and lifestyle 
modification. This report is based on a recent opinion piece by the Practice Committee of the American 
Society for Reproductive Medicine (ASRM).8 This report contains suggestions for optimizing the 
chances for achieving pregnancy for couples who have no evidence for infertility. 
Theoretical Reason for Focused Intercourse during the Six-Day Fertile Window 
A man and woman together are fertile for approximately six days during the menstrual cycle. These six 
days are known as the fertile window. This fertile time frame was confirmed by A.J. Wilcox and others 
in a classic study reported in a 1995 article in The New England Journal of Medicine.9 The six days are 
based on the physiological knowledge that a human female egg is viable and capable of being fertilized 
for only 12–24 hours after ovulation and that sperm will survive 3–5 days in a cervical mucus-enriched 
environment. 
The probabilities of achieving a pregnancy with an act of intercourse during those six days also have 
been determined to be approximately 10 percent, 15 percent, 20 percent, 39 percent, 40 percent, 
respectively on the five days before ovulation with the day of ovulation dropping off to 12 percent. The 
two most fertile days of the menstrual cycle are the two days before ovulation. Therefore, one would 
expect that having intercourse on the two days before ovulation, i.e., the high probability days, would 
increase the chances for pregnancy.10 Researchers also have determined that the fertile window is 
often shorter than six days and that the average is only three days in length.11 
Besides knowledge of the probability of pregnancy during the fertile window, there is knowledge of the 
probability of pregnancy on each day of the menstrual cycle based on population studies. Studies on 
women with fairly regular menstrual cycles, i.e., between 21–35 days in length, have shown that the 
highest probability of pregnancy is from day 8 (9.4 percent) to a peak around day 14 but drops to only 
2 percent by day 21.12 Based on these probabilities, the Practice Committee of the ASRM 
recommended that the likelihood of conception will increase by having frequent intercourse beginning 
soon after the cessation of menses.13 To assure having intercourse during the six-day fertile window, 
couples should have intercourse frequently during days 8–19 of the menstrual cycle. However, other 
factors come into play, such as frequency of intercourse, presence of cervical mucus, and the accuracy 
of methods to estimate the fertile phase. 
Frequency of Intercourse 
Recommendations for frequency of intercourse for couples with infertility problems are often a topic 
of discussion and a source of disagreement. Of particular concern is the decrease in sperm and semen 
quality with frequent intercourse patterns. However, the thinking now is that prolonged abstinence is 
deleterious to fertility (i.e., in particular semen quality) and that frequent intercourse is preferred. 
Researchers from Israel conducted a retrospective study with 9,489 semen analysis samples to 
evaluate the relationship between sexual abstinence and characteristics of semen. They found the 
peak in sperm motility to be after only one day of abstinence, while other semen values peaked from 
0–2 days of abstinence.14 The researchers recommended that the best semen samples come after one 
day of abstinence. In fact waiting longer, especially over 10 days, results in semen parameters with a 
decrease in quality.15 
A team of research statisticians from Italy and the United States have also investigated optimal 
intercourse patterns for the best chance of achieving pregnancy. They developed a statistical approach 
(based on Baysian modeling) to determine optimal rules for intercourse and found that the maximum 
probability of conception was 0.687 with intercourse every day between days 6 and 25 of the 
menstrual cycle (i.e., 20 acts of intercourse).16 However, having intercourse that often can be stressful 
for some couples. They also determined that the probability was still at 0.615 with 7 acts of intercourse 
during the same time period. It seems that the best timing of intercourse (so as not to be exhausting 
for couples) is to have intercourse every 2–3 days. The Practice Committee of the American Society of 
Reproductive Medicine recommended frequent intercourse (i.e., every 1–2 days), but that the optimal 
frequency should be left up to the couple to decide.17 
Focused Intercourse 
Focused Intercourse with Cervical Mucus 
There have been a number of studies that have shown the importance of the presence and quality of 
cervical mucus as a factor in optimal fertility. An existing data set was used by a multi-national group of 
researchers to determine the influence of cervical mucus observations on day-specific probabilities of 
pregnancy within the 6-day fertile window.18 The data set was obtained from the 1992–1997 European 
Study of Daily Fecundability in which 782 women between the ages of 18–40 recorded their daily 
observations of cervical mucus and basal body temperature (BBT). The researchers were able to use 
1,473 cycles of data with 353 pregnancies and determined that there was clear evidence for an 
increase in the probability of pregnancy with an increase in the mucus rating within the 6-day fertile 
window. Furthermore, there was a steady increase in pregnancy probability with each increase of the 
mucus rating. The researchers concluded that (within the fertile window) the type of mucus observed 
on the day of intercourse was more predictive of conception than the timing of intercourse. In 
addition, the highest rated mucus occurred most often on the 2 days before the estimated day of 
ovulation. They also observed that self-monitoring of cervical mucus provides additional information 
about fertility that is not provided by other methods or indicators of fertility, such as ultrasound and 
urinary LH testing. The application of these findings for women trying to achieve pregnancy using 
cervical mucus observations need to be confirmed in actual prospective studies. 
As men age, their reproductive capacity decreases. However, scientists were able to use the same data 
set described in the above report to determine day-specific probabilities of pregnancy in relation to 
cervical mucus quality on the suspected day of intercourse that resulted in a pregnancy and male 
reproductive age.19 Controlling for the female partner's age, researchers found that as the quality of 
cervical mucus increased, the effect of male age on fertility decreased. Specifically, among men in their 
late 30s and early 40s, when no mucus was observed, there was a 50 percent less likelihood of 
pregnancy from an act of intercourse; on days when a damp sensation was recorded, the less 
likelihood of a pregnancy decreased to 21 percent; on days of thick mucus, the less likelihood 
decreased to 11 percent; and on days with the most fertile-type mucus, the less likelihood decreased 
to only 4 percent. The researchers concluded that the age-related decline in male fertility can be offset 
with intercourse on optimal mucus (i.e., clear, stretchy, and slippery type mucus) days of the menstrual 
cycle. 
Italian researchers used the same data set of menstrual cycles and applied a statistical fecundity model 
to the data to determine day-specific probabilities of intercourse based on the mucus ratings as graded 
by NFP teachers.20 The results showed that there was a range of probability of pregnancy from an act 
of intercourse with the lowest (0.003) on days with no noticeable cervical mucus secretions to 0.290 on 
days with high-rated cervical mucus. However, the probability of a pregnancy from high-rated mucus 
was less than 20 percent outside of days 10–17 to a peak of 59 percent on day 13 of the menstrual 
cycle. The researchers concluded that, regardless the timing of intercourse during the menstrual cycle, 
the probability of pregnancy with an act of intercourse on days with no cervical secretion is near 0. 
They also stated that the probability increased dramatically to near 30 percent with the most fertile 
mucus. They concluded that cervical mucus secretions accurately predict both the timing of the fertile 
phase of the menstrual cycle and the day-specific probabilities of conception. 
Italian researchers also utilized a new data set of 2,755 menstrual cycles produced by 193 women 
users of the Billings Ovulation Method.21 The purpose was to determine characteristics of the 
menstrual cycle, mucus-cycle patterns, intercourse patterns, and day-specific probabilities of fecundity. 
The 193 women users were taught the Billings Ovulation Method at 4 natural family planning (NFP) 
centers in Italy. The peak day of cervical mucus was set as day 0 and was used as the estimate of the 
day of ovulation. There were 142 conception cycles produced from this data set. Day-specific 
probabilities of pregnancy were based on a 12-day period, from 8 days before day 0 (i.e., the estimated 
day of ovulation) to 3 days after, and determined by the Schwartz Statistical Model. They found that 
there was some probability of pregnancy from an act of intercourse during 11 days of the 12-day study 
period, with the lowest probability (0.012) 7 days before day 0 and the highest (0.429) on day 0. The 
highest level of probability was from 4 days before day 0 until one day after, i.e., a 5–6 day period. 
Utilizing the same data set as described above (i.e., data produced by 193 women who were taught a 
mucus-only (Billings) method of natural family planning), researchers developed multiple scenarios of 
intercourse patterns with or without mucus during the middle most fertile days of the menstrual cycle 
(i.e., days 6–25) and during the estimated highest probability of fertility (i.e., days 13–17).22 They 
discovered that when intercourse is focused only on those days and not outside of days 6–25, the 
highest probability of pregnancy was with intercourse on each day from days 6–25 (i.e., 20 acts of 
intercourse). This pattern of daily intercourse yielded a cycle probability of conception = 0.687. This 
pattern also resulted in only 3 cycles of trying to achieve a 90 percent pregnancy rate. For couples who 
focused intercourse on the high-rated fertile mucus during days 13–17 of the menstrual cycle, the cycle 
probability of conception decreases to 0.347, with a mean intercourse rate of 2.42 days. With this 
scenario, the number of cycles to achieve a 90 percent pregnancy rate would take an average of 15 
cycles. 
Interestingly, if the couples have intercourse (on average) every other day (regardless of the mucus 
rating) and focus on days 10–18 of the menstrual cycle, the cycle probability of conception drops only 
slightly to 0.647 and increases one additional cycle to pregnancy (i.e., 4 cycles) to achieve a 90 percent 
pregnancy rate. 
The authors concluded that focusing intercourse on days of high-rated fertile mucus would be useful 
for couples to shorten their time to pregnancy and not require a high frequency of intercourse. They 
also admitted that just using a calendar method and having intercourse on average every other day 
during the estimated fertile window and occasionally outside of the fertile window are sufficient to 
shorten the time to pregnancy. With this scenario, mucus identification does not add to the efficiency 
of achieving pregnancy. 
The intercourse scenarios presented in this study are theoretical and need to be tested in actual life 
and, in particular, with randomized control trials—for example comparing calendar-based intercourse 
patterns versus high-rated fertile mucus focused intercourse patterns. It seems, based on this 
theoretical data, that intercourse every other day during the estimated fertile phase of the cycle has 
very high probability of efficiently achieving a pregnancy. 
Members of the practice committee of the ASRM do not provide much of a recommendation about 
cervical mucus and fecundity other than to say the 6-day fertile window correlates well with the 
volume and quality of cervical mucus.23 Part of the reason for not recommending cervical mucus 
monitoring and having intercourse on the high-rated fertile mucus might be due to the time that it 
might take to teach and learn mucus patterns during the menstrual cycle. 
Monitoring Ovulation to Achieve Pregnancy with Focused Intercourse 
J.B. Stanford and D.B. Dunson recently published a paper illustrating models of the relationship 
between the frequency and timing of intercourse and time to pregnancy.24 They point out that merely 
including frequency of intercourse is not adequate because of the variability of the day-specific 
probabilities of pregnancy within the six-day fertile window. For example, if a couple has intercourse 
outside of this window of fertility (no matter how frequently), there will be a very small probability of 
pregnancy. They also point out that there might be intercourse patterns found in different cultures and 
that intercourse could be stimulated by libido patterns that peak during the fertile window. 
The authors recommend that prospective time-to-pregnancy studies include the frequency and timing 
of intercourse relative to the six-day fertile window, and to do this by having the participants chart 
their daily intercourse patterns. They recommended that the fertile window could be estimated by use 
of basal body temperature, home urinary hormonal tests, or the observations of cervical-vaginal 
mucus. 
Stanford, K.R. Smith, and Dunson also conducted a study to determine the day-specific probabilities of 
pregnancy in relation to the timing of intercourse and the quality of self-observed vulvar mucus among 
a group of normal and sub-fertile couples.25 The couples were obtained from six different Creighton 
Model Fertility Care System centers in four different cities (in Missouri, Nebraska, Kansas, and 
California). The Creighton Model (CrM) is a cervical mucus system of natural family planning that 
utilizes a standardized vulvar discharge recording system. The researchers retrospectively obtained 
two groups of CrM system users, one group entailed couples with normal fertility that had the initial 
intention of avoiding pregnancy, and the other group consisted of couples that were defined as sub-
fertile based on having previous difficulty in achieving pregnancy. There were 309 couples in the 
normal fertility group that generated 1,681 usable data charts, and 117 couples in the sub-fertile group 
that yielded 373 cycles of usable data. Two research assistants and one researcher identified the peak 
day for each cycle and the day or days of intercourse 6 days before and 4 days after the peak day of 
cervical mucus. The researchers found 81 pregnancies among the 1,681 cycles from the couples of 
normal fertility and 30 pregnancies among the 373 cycles of data from the couples with sub-fertility. All 
pregnancy cycles had acts of intercourse 6 days before to 3 days after the peak day of cervical mucus. 
The researchers calculated that the highest probability of conception was on the peak day of cervical 
mucus with a probability of 0.38 for couples of normal fertility and 0.14 for sub-fertile couples. The 
researchers concluded that a standardized system of rating vaginal mucus discharges can help couples 
of normal fertility and of sub-fertility identify the days of the menstrual cycle that have the greatest 
likelihood of conception. They also speculated that the highest probability of pregnancy occurred on 
the peak mucus day, their estimated day of ovulation. 
There have been very few prospective studies on pregnancy rates with couples using fertility focused 
intercourse with the aid of methods to monitor fertility and to estimate the beginning, peak, and end 
of the fertile window, as recommended by Stanford and Dunson. T.W. Hilgers reported a study in 
which 49 of 50 couples (of normal fertility) achieved a pregnancy within 5 months by focusing 
intercourse on days of good quality cervical mucus.26 German researchers reported the largest 
prospective study to estimate the cumulative probabilities of conception among a cohort of 346 
couples using the symptothermal method (i.e., cervical mucus and basal body temperature monitoring) 
from their first cycle onwards.27 There were a total of 310 pregnancies among the 346 couples during a 
maximum of 29 cycles of observation. The researchers labeled the couples that achieved a pregnancy 
as “truly fertile.” The cumulative pregnancy rates for cycles 1, 3, 6, and 12 for all couples (N = 340) 
were 0.38, 0.68, 0.81, and 0.92 respectively. For the truly fertile couples (N = 304), the pregnancy rates 
at cycles 1, 3, 6, and 12 were 0.42, 0.75, 0.88, and 0.98. Therefore, close to 90 percent of the truly 
fertile couples and close to 80 percent of all couples in the study achieved a pregnancy within the first 
6 cycles of fertility-focused intercourse. Based on the results of this study, the researchers 
recommended that couples who do not achieve a pregnancy within a 6-month time period of fertility-
focused intercourse seek a primary infertility workup. However, they also recommended that these 
couples continue fertility-focused intercourse for another 12 months. 
A new, high-tech, electronic method to monitor fertility has recently been developed to help women 
determine their fertile window with ease, convenience, and accuracy.28 This high-tech, electronic, 
hormonal fertility monitor (EHFM), called the Clear-Blue Easy Fertility Monitor (Inverness Medical 
Innovations), estimates the fertile window using urinary metabolites of estrogen and LH and provides 
the user with a daily indication of “low,” “high,” and “peak” fertility. Researchers from Unipath 
Diagnostics completed a study in which they randomized 1,000 women volunteers into two groups, 
one group of 500 received an EHFM, and the control group of 500 women volunteers were asked to do 
what they wished to achieve a pregnancy, including the use of pregnancy-assist devices (e.g., ovulation 
test kits and basal body temperature).29 The volunteers were between the ages of 21–40 years and 
with a partner between the ages of 21–50. The pregnancy rate during the first cycle was 15.2 percent 
(or 46 of 302) for the EHFM group and 7.8 percent (27 of 347) for the control group. The two-cycle 
cumulative pregnancy rate was statistically higher for the EHFM at 22.7 percent compared with the 
control group at 14.4 percent (p=0.006). They also found that having a previous pregnancy and a young 
partner were significant factors for achieving a pregnancy. In addition, the researchers provided the 
users of the EHFM with a satisfaction tool and determined that 90 percent of the users found the 
device to be easy or very easy to use, and 80 percent found it to be convenient or very convenient. 
They concluded that the EHFM helped increase the likelihood of pregnancy during the first 2 cycles of 
use compared to nonuse among women trying to conceive for up to 2 years. It would be nice to see a 
similar study among women with normal fertility to discover what normal pregnancy rates would be 
with use of the monitor in comparison with a control group. 
There is little evidence to show that focused intercourse during the fertile time as estimated by self-
monitoring of natural biological markers of fertility will increase the pregnancy rate and decrease the 
time to pregnancy. Only one randomized trial comparing self-indicators of fertility to estimate the 
fertile phase and timed intercourse exists. In fact, there have been claims in the scientific literature 
that focused intercourse based on the estimation of fertility is no better than having intercourse 2–3 
times a week.30 The National Institute for Clinical Excellence (NICE) guidelines specifically state that use 
of focused intercourse is too stressful and no more effective than having intercourse 2–3 time per 
week.31 The ASRM policy committee recommended that electronic or other devices that are designed 
to aid the couple to determine the optimal time of fertility may be useful for couples who have 
infrequent intercourse.32 
Studies on Lifestyle Factors and Fertility 
There are many lifestyle factors that can affect fertility. Some factors need to be avoided or moderated 
(e.g., caffeine and alcohol), some avoided all together (e.g., smoking), and others added to a lifestyle 
(e.g., better nutrition). The ARSM review focused on diet, smoking, alcohol, caffeine, and other 
considerations. 
Alcohol and Fertility 
Danish researchers conducted one of the largest studies on the relationship between alcohol 
consumption and fertility.33 They surveyed 39,612 women on their alcohol consumption and waiting 
time to get pregnant. All of these women were within their first 24 weeks of pregnancy. They 
discovered that moderate and high consumption of alcohol was not associated with longer waiting 
times to pregnancy. The only group of women alcohol drinkers that had a significantly longer waiting 
time to pregnancy were those who drank on average more than 14 alcoholic drinks per week and had 
previous pregnancies. In fact, women who had a low consistent alcohol intake of 1–2 drinks per week 
had a shorter waiting time period than those who were non-drinkers. The authors speculated that 
moderate amounts of alcohol may have a positive effect on the female reproductive system, especially 
by the way of stress reduction. Although the authors did not find a prolonged waiting time to 
pregnancy among moderate alcohol drinkers, they did find a longer waiting time among smokers, 
overweight women, and older women. 
The ASRM policy committee stated that higher levels of alcohol consumption (i.e., greater than or 
equal to 2 drinks per day) should be avoided when attempting pregnancy. Moderate alcohol 
consumption (defined as 1–2 drinks per day) has no adverse effect on fertility.34 They also warned that 
this implies before pregnancy. No “safe” level of alcohol consumption has been established during 
pregnancy. 
Caffeine and Fertility 
Researchers from the Division of Epidemiology, Statistics, and Preventive Research from the National 
Institute of Child Health and Human Development and from the Center of Human Toxicology at the 
University of Utah measured serum paraxanthine (a metabolite of caffeine) in 591 women who had 
spontaneous abortions and in 2,558 matched women from the same clinic who gave birth to live 
infants.35 They found that only very high serum paraxanthine concentrations (an equivalent of more 
than 5 cups of coffee per day) were associated with spontaneous abortion. They concluded that a 
moderate intake of caffeine should not increase the risk of spontaneous abortion. 
A research team from Sweden and the United States conducted another study on the effects of 
caffeine and found that the equivalent of 1–3 cups of American coffee increased the risk of miscarriage 
by 30 percent and 3–5 cups raised the risk by 40 percent.36 The study involved 562 Swedish women 
who had miscarriages at between 6–12 weeks of pregnancy. These women were matched with 953 
who did not have spontaneous abortion. The director of the study (Dr. Sven Cnattingius) 
recommended that pregnant women limit their caffeine intake to about 2 American cups per day. A 
typical American cup of coffee has about 100 milligrams of coffee as compared to a Swedish cup, which 
has about 180 milligrams. A critique of the results is that the study might be biased towards including 
women with unhealthy fetuses. Women who have healthy fetuses usually experience more morning 
sickness and, thus, tend not to drink strong aroma beverages like coffee. 
The ASRM policy committee recommendation is that moderate caffeine intake (i.e., one to two cups of 
coffee per day or its equivalent) before or during pregnancy has no apparent effect on fertility or 
pregnancy outcomes.37 
Obesity and Fertility 
A group of U.S. researchers conducted a study to examine the obesity-fecundity association in relation 
to parity, menstrual regularity, smoking habits, and age.38 The data for this study was taken from the 
1959–1965 Collaborative Perinatal Project that involved a subset of 7,327 women that had planned 
pregnancies, recorded their time to pregnancy, and recorded their height and weight (so the authors 
could calculate their body mass index). The women were classified by their level of body mass index to 
be one of 4 weight categories: underweight, optimal weight, over-weight, and obese. As expected, 
there was an increased time to pregnancy for older women, smokers, and women with irregular 
menstrual cycles (about 8 percent of the women). The researchers also found that fecundity odds 
ratios (FOR) were reduced for underweight (FOR = 0.94), for overweight (FOR = 0.84), and obese (FOR = 
0.63) women when compared to optimal-weight women. Smoking habits and age did not modify this 
association. The authors speculated that the reason for decreased fecundity could be due to increased 
estrogen levels in the fat cells that interfere with the hypothalamic-ovarian axis. The authors 
recommended weight loss and knowledge of the fertile phase of the menstrual cycle for overweight 
and obese women seeking pregnancy. 
Researchers from the National Institute of Environmental Health Sciences (NIEHS) also investigated the 
influence of male obesity on infertility.39 There have been few population-based studies to determine 
the influence of body mass and infertility among males, and there are no studies that examined coital 
frequency as a confounding factor. Therefore, NIEHS scientists conducted a study to determine the 
influence of being overweight, i.e., having a body mass index (BMI) of 25 or over, in association with 
infertility that included frequency of intercourse around the time of conception as a confounding 
variable. This study was retrospective and population-based, utilizing data from the ongoing 
Norwegian Mother and Child Cohort Study (MoBa). The MoBa study aimed to enroll 100,000 pregnant 
women from 52 hospitals and birthing centers throughout Norway. Available to the NIEHS researchers 
were 45,132 women participants, of whom 26,303 met the study criteria and included the women's 
reports of the men's height and weight. The researchers found that infertility was significantly related 
to the man's body mass index, with overweight men having a 19 percent increase in infertility (OR = 
1.19: 95 percent CI = 1.03–1.37) and obese men having a 36 percent increase incidence of infertility 
(OR = 1.36: 95 percent CI = 1.12–1.62). When the Odds Ratios were adjusted for coital frequency, there 
was not much of a change in results with an OR of 1.20 for overweight men and an OR of 1.36 for 
obese men. The results did not change as well when adjusted for age and parity of the woman. The 
researchers speculated that the increase in infertility among obese men was due to a decrease in 
reproductive hormone levels and a decrease in sperm production. They also speculated that weight 
loss would improve their chances of conception. 
Fertility awareness and NFP teachers working with couples who wish to achieve a pregnancy should 
assess the body mass index levels of both the woman and her male partner. If either has a body mass 
index over 25, weight loss might be recommended. For women who have a body mass index lower 
than 19, proper diet and weight gain would be recommended. The ASRM policy committee did not 
make any recommendation on weight other to say that women who are either too thin or obese will 
have decreased fertility.40 
Diet and Fertility 
Researchers from the Stanford University School of Medicine (Department of Gynecology and 
Obstetrics) conducted a study to determine the effects of a nutritional fertility supplement called 
FertilityBlend on the pregnancy rates of sub-fertile women.41 The participants were 93 women who 
tried unsuccessfully to achieve a pregnancy for 6 to 32 months. The FertilityBlend contained 
chasteberry, green tea, vitamins, folate, and minerals. The outcome measures were serum 
progesterone levels, number of days basal body temperatures were above base line, menstrual-cycle 
length, pregnancy rates, and side effects. The study design was doubleblind and placebo-controlled. 
The 53 participants in the FertilityBlend group had significantly increased progesterone levels above 
basal treatment, significantly increased basal body temperatures over 98 degrees, and significantly less 
variability in the menstrual-cycle length (i.e., fewer long and short cycles). The control group of 40 
women did not show a significant change over time on these outcomes variables. After 3 months of 
use, 14 of the 53 women in the FertilityBlend group were pregnant (26 percent) as compared to only 4 
of the 40 women (10 percent) in the placebo group. This was a statistically significant difference in 
pregnancy rates between the 2 groups. The researchers concluded that the FertilityBlend nutritional 
supplement could be a beneficial alternative or complementary therapy to traditional infertility 
treatments. 
An exciting study was conducted by Harvard University researchers who sought to determine the 
association of a “fertility diet” on the incidence of ovulatory infertility.42 The participants for this study 
were a subset of the Nurses’ Health Study (NHS) that began in 1989 with 116,671 female United States 
registered nurses between the ages of 24 to 42 years who were followed with a mailed questionnaire 
every 2 years. Of these participants 17,544 women without a history of infertility were followed for 8 
years as they tried to achieve pregnancy. All were provided a dietary score based on a fertility diet that 
was high in plant protein, low in animal fat, low in refined carbohydrates, high in fiber, and high in 
high-fat dairy products. They found that the increased adherence to the “fertility diet” was associated 
with a lower risk of ovulatory disorder infertility. They also found that a lifestyle of diet, weight control, 
and physical activity was associated with a 69 percent lower risk of ovulatory disorder. 
These same researchers also recently studied the effects of multivitamin intake on another subset of 
the NHS.43 When adjusted for age and calendar time, multivitamin users had approximately a one-third 
lower risk of developing ovulatory infertility than nonusers (p < 0.001). The association of multivitamin 
use was dose dependent in that there was no difference in risk of infertility with those who consumed 
2 or less multivitamins per week. The researchers estimated that 20 percent of ovulatory infertility 
could be avoided if women consumed 3 or more multivitamins per week. The ASRM, however, stated 
that there is little evidence that vegetarian diets, low-fat diets, vitamin-enriched diets, anti-oxidants, or 
herbal remedies improve fertility.44 They did recommend that women attempting pregnancy should 
take a folic acid supplement to decrease the risk of neural tubal defects. 
Other Lifestyle Factors and Menstrual Cycle Variability 
Researchers from the Postgraduate Medical Institute at the University of Hull, England, conducted an 
observational study in which they administered a lifestyle and time-to-pregnancy (i.e., the interval of 
exposure to unprotected intercourse from discontinuing birth control methods until conception) 
questionnaire to 2,112 pregnant women who attended antenatal clinics in Hull and East Yorkshire, 
England.45 They had a 99.0 percent response rate to this questionnaire. 
Overall, they found that 57.1 percent of these women conceived within 3 months and 81.2 percent by 
the end of 12 months. Of the 372 (18.8 percent) sub-fertile couples, 190 (9.6 percent) conceived by the 
end of the second year of trying. The sub-fertile couples compared to the fertile couples were 
significantly older, more obese, smoked more cigarettes, and consumed more alcohol. 
More specific results showed that heavy smoking women (>15 cigarettes/day) compared to light 
smoking or non-smoking women had a twofold longer time to pregnancy. Heavy smokers were more 
likely to be sub-fertile among both men and women. Heavy alcohol consumption among the male 
partner was associated with a twofold increase in time to pregnancy. Moderate alcohol consumption 
among women and their partners was found to have no effect on time to pregnancy. Women who 
drank >5 cups of tea or coffee per day had a longer time to pregnancy and were more likely to be 
subfertile. Women who were over- and underweight had problems with fertility. Underweight women 
had a fourfold longer time to pregnancy, and women who were overweight had a twofold longer time 
to pregnancy. Underweight women were 3.5-fold and obese women were 3.8-fold more likely to be 
sub-fertile. Women participants who had a lower living standard had a longer time to pregnancy and 
were more likely to be sub-fecund than those women who had high living standards. Finally, 
recreational drug use and coital frequency had no significant effect on time to pregnancy or sub-
fecundity. However, the incidence of recreational drug use was low, and, thus, statistical power to 
determine risk was decreased. 
The researchers also found that, as the number of negative lifestyle factors increased, there was a 
significant and progressive increase in time to pregnancy and a significant reduction in fecundity. The 
mean time to pregnancy with 2 negative lifestyle variables was 2.5-fold, 3.7-fold with 3 variables, and 
4.4-fold with 4 variables. Couples who had more than 4 negative lifestyle variables had a 7.3-fold 
longer time to pregnancy compared with couples that had none. The researchers recommended 
promoting healthy lifestyles among couples planning for or trying to achieve a pregnancy. Based on 
their results they concluded that couples who lead healthy lifestyles should cut their rate of sub-
fecundity in half. 
Helping couples lead a healthy lifestyle will not only help them to have better general health but also 
increased fertility. This could lead to a substantial decline in medical referrals and treatment for 
infertility and, thus, a substantial reduction in health costs. The ASRM policy committee recommended 
that smoking, high-level alcohol consumption, and recreational drugs (e.g., marijuana), should be 
avoided for couples attempting pregnancy.46 
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